- AVXL -4.08%
Anavex Life Sciences (NASDAQ:AVXL) Is In A Good Position To Deliver On Growth Plans
Yahoo Finance · 3 days ago
Open | 4.1800 |
High | 4.2100 |
Low | 3.9550 |
Mkt Cap | 338.57M |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 4.1700 |
52 Wk. Low | 3.2500 |
52 Wk. High | 10.4500 |
Related stocks
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | - | - |
Net Income | -10.55M | - |
Diluted EPS | -0.13 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.13 | - |
Q1 2024 | -$0.11 | -$0.13 |
Q4 2023 | -$0.14 | -$0.11 |
S&P 500^GSPC | 5,304.72+36.88 (+0.70%) |
Dow 30^DJI | 39,069.59+4.33 (+0.01%) |
Nasdaq^IXIC | 16,920.79+184.76 (+1.10%) |
0.9830+428.49% | |
809.73+1.68% | |
Workday, Inc.WDAY | 220.91-15.33% |